Craig Stapleton

Track

Insider profile

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 70% 68% 82%
Transactions
6 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Non-Executive Independent Chairman of the Board Avadel Pharmaceuticals PLC July 1, 2014 - May 9, 2019
Independent Director Abercrombie & Fitch Co Jan. 27, 2014 - June 1, 2017
Independent Director Avadel Pharmaceuticals PLC June 24, 2011 - July 1, 2014
Lead Independent Director Abercrombie & Fitch Co Feb. 23, 2010 - Jan. 27, 2014
Craig Stapleton's trades of Avadel Pharmaceuticals PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2017-09-14 2017-09-12
B Purchase
56,988 -45.3%
384.85
US$3,342,575 		56,988 -45.3% 384.85 US$3,342,575
2016-11-30 2016-11-29
B Purchase
51,335 -28.6%
405.11
US$536,090 		51,335 -28.6% 405.11 US$536,090
2016-09-06 2016-09-01
B Purchase
56,855 +33.6%
400.20
US$2,106,982 		56,855 +33.6% 400.20 US$2,106,982
2016-08-29 2016-08-26
B Purchase
9,122 +83.9%
13.67
US$124,698 		9,122 +83.9% 13.67 US$124,698
2016-08-29 2016-08-26
B Purchase
10,878 +inf%
13.83
US$150,443 		10,878 +inf% 13.83 US$150,443
2016-03-16 2016-03-14
B Purchase
100,000 +26.1%
10.39
US$1,039,400 		100,000 +26.1% 10.39 US$1,039,400